Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,601
Total Claims
$698K
Drug Cost
497
Beneficiaries
$1,404
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+39%
Opioid rate vs peers
5.3% vs 3.8% avg
+20%
Cost per patient vs peers
$1,404 vs $1,174 avg
+35%
Brand preference vs peers
12.0% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
5.3%
Opioid Rate
347
Opioid Claims
$12K
Opioid Cost
20.2%
Long-Acting Rate
Brand vs Generic
Brand: 781 claims · $533K
Generic: 5,724 claims · $161K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 56 | $76K |
| Sitagliptin Phosphate | 61 | $69K |
| Empagliflozin | 37 | $49K |
| Apixaban | 32 | $42K |
| Semaglutide | 27 | $35K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $21K |
| Linagliptin | 12 | $18K |
| Buprenorphine Hcl/Naloxone Hcl | 86 | $18K |
| Insulin Degludec | 12 | $16K |
| Linaclotide | 23 | $15K |
| Budesonide/Formoterol Fumarate | 33 | $15K |
| Insulin Detemir | 11 | $13K |
| Umeclidinium Brm/Vilanterol Tr | 18 | $13K |
| Tiotropium Bromide | 15 | $12K |
| Buprenorphine Hcl/Naloxone Hcl | 15 | $8,271 |
Prescribing Profile
Patient Profile
70
Avg Age
69%
Female
1.17
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About